Literature DB >> 19204275

Use of antihypertensives and the risk of Parkinson disease.

Alberto Ascherio, Caroline M Tanner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19204275     DOI： 10.1212/01.wnl.0000344171.22760.24

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  L-type calcium channel blockers and Parkinson disease in Denmark.

Authors:  Beate Ritz; Shannon L Rhodes; Lei Qian; Eva Schernhammer; Jørgen H Olsen; Søren Friis
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

Review 2.  Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.

Authors:  Joshua J Gagne; Melinda C Power
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

3.  Calcium channel blocker use and risk of Parkinson's disease.

Authors:  Kelly Claire Simon; Xiang Gao; Honglei Chen; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

4.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

5.  Importance of the brain Angiotensin system in Parkinson's disease.

Authors:  John W Wright; Joseph W Harding
Journal:  Parkinsons Dis       Date:  2012-11-07

6.  Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

Authors:  Hua Huang; Cheng Yang Ng; Dejie Yu; Jing Zhai; Yulin Lam; Tuck Wah Soong
Journal:  Nat Commun       Date:  2014-07-24       Impact factor: 14.919

7.  Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity.

Authors:  Daniel Ho; William Schierding; Sophie L Farrow; Antony A Cooper; Andreas W Kempa-Liehr; Justin M O'Sullivan
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.